Sulfinpyrazone
From Wikipedia, the free encyclopedia
| Image:Sulfinpyrazone.png | |
|
Sulfinpyrazone
|
|
| Systematic (IUPAC) name | |
| 1,2-diphenyl-4-(2-phenylsulfinylethyl) pyrazolidine-3,5-dione | |
| Identifiers | |
| CAS number | 57-96-5 |
| ATC code | M04AB02 |
| PubChem | 5342 |
| DrugBank | APRD00620 |
| Chemical data | |
| Formula | C23H20N2O3S |
| Mol. weight | 404.483 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 98-99% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Sulfinpyrazone is a uricosuric medication used to treat gout.
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
